CLXT - Calyxt, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Calyxt, Inc.

2800 Mount Ridge Road
Roseville, MN 55113-1127
United States
651 683 2807

Full-time employees48

Key executives

NameTitlePayExercisedYear born
Mr. Michael Allen CarrPres, CEO & Director543.56kN/A1970
Mr. William F. KoschakChief Financial Officer356.74kN/A1969
Dr. Travis J. Frey Ph.D.Chief Technology Officer314.76kN/A1979
Ms. Debra H. FrimermanGen. Counsel & Corp. Sec.334.08kN/A1980
Dr. Daniel F. Voytas Ph.D.Founder, Chief Science Officer & Chair of Scientific Advisory BoardN/AN/A1963
Dr. Stephen M. BravoChief Medical OfficerN/AN/AN/A
Mr. Gerry NuovoSr. VP of Bus. Devel.N/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.

Corporate governance

Calyxt, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.